{"ModuleTitle": "Company Description", "CompanyName": "PDL BioPharma, Inc.", "Symbol": "PDLI", "Address": "932 SOUTHWOOD BLVD, INCLINE VILLAGE, Nevada, 89451, United States of America", "Phone": "775-832-8500", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "In this report all references to \"PDL,\" \"we,\" \"us,\" \"our\" or the \"Company\" mean\r\ncollectively PDL BioPharma, Inc. and its subsidiaries, except where it is made\r\nclear that the term means only PDL BioPharma, Inc.\r\n\r\nThroughout our history, our mission has been to improve the lives of patients by\r\naiding in the successful development of innovative therapeutics and healthcare\r\ntechnologies. PDL BioPharma was founded in 1986 as Protein Design Labs, Inc.\r\nwhen it pioneered the humanization of monoclonal antibodies, enabling the\r\ndiscovery of a new generation of targeted treatments that have had a profound\r\nimpact on patients living with different cancers as well as a variety of other\r\ndebilitating diseases. In 2006, we changed our name to PDL BioPharma, Inc.\r\n\r\nIn September 2019, we engaged financial and legal advisors and initiated a\r\nreview of our strategy.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f11%2f0000882104-20-000032.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Dominique Monnet", "title": "President, Chief Executive Officer & Director"}, {"name": "Edward A. Imbrogno", "title": "Chief Financial & Accounting Officer, VP"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}